Episode 131: VTE Series-Approach to workup and initial management 

This week, we kick off a new, highly-anticipated and highly-requested series, covering venous thromboembolism (VTE). In this first episode, we discuss how we make the initial diagnosis and how we approach initial management. As a clinician, you will undoubtedly come across the need to make this decision. This episode and this series will set you up for success!

Episode 130: Testicular Cancer Series, Pt 4 - Role of Radiation Oncology

This week, we welcome Dr. Amar Kishan to our show to discuss the role of radiation oncology in the management of patients with testicular cancer. As our listeners know by now, the management of patients with testicular cancer spans multiple specialities. We always appreciate hearing from our colleagues about their perspective.

Episode 129: Testicular Cancer Series, Pt 3 - Disseminated and relapsed/refractory disease 

This week, we talk all about disseminated testicular cancer, highlighting our current treatment modalities and why we do what we do. We also cover refractory disease. This episode builds on our prior discussions in Parts 1 and 2, so be sure to check these out if you haven’t already!

Episode 128: Testicular Cancer Series, Pt 2 - Stage 1 and 2

This week, we continue on our testicular cancer journey, focusing on Stage 1 and 2 disease. If you haven’t done so, we highly recommend checking out Episode 127 for our overview of this disease!

Episode 127: Testicular Cancer Series, Pt 1 - Introduction

It’s time for another new series, this time focusing on Testicular Cancer. In this first episode, we lay the foundation for our future discussions and discuss the basics of Testicular Cancer. 

Episode 126: AML Series, Pt 12 - Treatment of patients with relapsed/refractory disease 

This week, we round out our AML series with a detailed discussion about the approach to management of relapsed and refractory disease. This has been a VERY long road going through all management of AML. We hope that you have continued to build on our discussions week-to-week. An exciting treatment paradigm that is ever-evolving!

Episode 125: AML Series, Pt 11 - Treatment of patients unfit for intensive therapy

In today’s episode, we discuss how to approach AML treatment for patients who are unfit for intensive therapy.

Episode 124: AML Series, Pt 10 - Allogeneic transplant for AML

In today’s episode, we welcome back Dr. Amar Kelkar for part 2 of our two-part discussion on allogeneic transplant. In this episode, we build on our prior discussion regarding transplant, this time focusing on transplant for the treatment of AML.

Episode 123: AML Series, Pt 9 - Introduction to Allogeneic Transplant

In today’s episode, we welcome back Dr. Amar Kelkar for part 1 of our two-part discussion on allogeneic transplant. In this episode, we discuss the fundamental approach to patient selection and stem cell source selection. As you all know from this series, allogeneic transplants play a pivotal role in the management of AML. Dr. Kelkar’s pearls of wisdom help make this confusing topic so much more approachable!

Episode 122: AML Series, Pt 8 - AML Maintenance Therapies

This week, we continue our discussion on consolidation and maintenance therapies for AML, this focusing specifically on the maintenance component. This episode builds on our consolidations episodes (Ep. 120 and 121) so if you have not listened to this just yet, we highly recommend doing so!

Episode 121: AML Series, Pt 7 - AML Consolidation: Role of Allogeneic Transplant

This week, we continue our discussion on consolidation and maintenance therapies for AML, this time highlighting the role of allogeneic stem cell transplants. This episode builds on our prior episode, so if you have not listened to this just yet, we highly recommend doing so!

Episode 120: AML Series, Pt 6 - AML Consolidation: Therapeutic Approaches 

This week, we move to our next phases of therapy for AML, which are consolidation and maintenance. Be sure to check out our prior episodes for a discussion on initial workup and how we incorporate recurrent genetic abnormalities into how we think about AML. Check out figure 1 from this paper for a helpful diagram!

Episode 119: AML Series, Pt 5 - AML Induction: Options for Upfront Therapy 

This week, we round out our discussion regarding AML induction, this time focusing on the treatment options in the first line setting. We go through the various options, the dosing strategies, and the data behind them. 

Be sure to check out parts one and two of this three-part induction discussion, as we continue to build on these concepts! Also, if you have not done so, please do check out our hemepath series to ensure you can more easily follow along with this conversation!

Episode 118: AML Series, Pt. 4 - AML Induction: Approach to Initial Management 

In this week’s episode, we continue onto part two of our three-part discussion on AML induction, this week focusing on selecting our up-front regimen. 

Be sure to check out last week’s episode, as this one builds on that one. Also, if you have not done so, please do check out our hemepath series to ensure you can more easily follow along with this conversation!

Episode 117: AML Series, Pt. 3 - AML Induction: Definitions and Overview

In this week’s episode, we start our three-part discussion on AML induction, this week focusing on key definitions and an overview of treatment.

Also, if you have not done so, please do check out ourhemepath series to ensure you can more easily follow along with this conversation!

Episode 116: AML Series, Pt. 2 - MDS/AML Diagnosis and Risk Stratification

In this week’s episode, we discuss the diagnostic criteria and risk stratification for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), building on our discussion from last week. Also, if you have not done so, please do check out our hemepath series to ensure you can more easily follow along with this conversation!

Episode contents:

- A review of what to look at on the bone marrow biopsy report

- WHO and ICC classification for AML and MDS

- Disease-defining cytogenetic markers to be aware of and their prognostic implications

Episode 115: AML Series, Pt. 1 - CHIP, CCUS, ICUS, oh my!

This week, we kick off a new series focusing on myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). In this first episode, we discuss the alphabet soup of premalignant hematologic conditions including CHIP, CCUS, and ICUS, before moving onto MDS and AML in future episodes.

By popular demand, our next series that we are excited to share with you is on MDS/AML! As we prepare for the release of the first episode next week, let’s throw it back to Episode 019 in our Heme/Onc Emergencies Series and talk about APL!

Episode 113: Sickle Cell Series - Chronic Management of Sickle Cell Disease

In this week’s episode, we discuss the management of sickle cell disease in the chronic setting. This is a follow up to episode 111 where we discussed acute management of SCD. And furthermore, this is also in addition to our prior discussion about long-term chronic complications from SCD in episode 110. We highly recommend checking out these prior episodes if you haven’t done so already!

Episode 112: Sickle Cell Series - Chronic Management of Sickle Cell Disease

In this week’s episode, we discuss the management of sickle cell disease in the chronic setting. This is a follow up to episode 111 where we discussed acute management of SCD. And furthermore, this is also in addition to our prior discussion about long-term chronic complications from SCD in episode 110. We highly recommend checking out these prior episodes if you haven’t done so already!